← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2010Last known activity
Jun 15, 2020
Timeline
2000s
- Jun 1, 2000
Immunitor LLC— Founded
Drugs by trial phase (12 distinct, 14 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Indications
Recent trials (28)
- NCT04380532CollaboratorPhase 1/Phase 2Jun 15, 2020
- NCT04380532Lead sponsorPhase 1/Phase 2Jun 15, 2020
- NCT03572361Lead sponsorPhase 2Jul 1, 2018
- NCT03550755Lead sponsorPhase 2Jul 1, 2018
- NCT03550755Study chairPhase 2Jul 1, 2018
- NCT03556566Lead sponsorPhase 2Jul 1, 2018
- NCT03556566Study chairPhase 2Jul 1, 2018
- NCT03572361Overall official - principal investigatorPhase 2Jul 1, 2018
- NCT03550703Lead sponsorPhase 2Jun 1, 2018
- NCT03550703Study chairPhase 2Jun 1, 2018
- NCT03340324Lead sponsorPhase 2Oct 1, 2017
- NCT03165591Lead sponsorPhase 1/Phase 2May 1, 2017
- NCT03165591Study chairPhase 1/Phase 2May 1, 2017
- NCT03042182Lead sponsorPhase 1/Phase 2Feb 20, 2017
- NCT03042182Study directorPhase 1/Phase 2Feb 20, 2017
Details
- Founded
- Chachoengsao, TH Jun 1, 2000
- Last known activity
- Jun 15, 2020